| Product NDC: | 0378-8250 |
| Proprietary Name: | Clarithromycin |
| Non Proprietary Name: | clarithromycin |
| Active Ingredient(s): | 250 mg/1 & nbsp; clarithromycin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0378-8250 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065195 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130304 |
| Package NDC: | 0378-8250-91 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-8250-91) |
| NDC Code | 0378-8250-91 |
| Proprietary Name | Clarithromycin |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-8250-91) |
| Product NDC | 0378-8250 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clarithromycin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130304 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | CLARITHROMYCIN |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |